Abstract
We designed a phase II trial of the combination with oxaliplatin and doxorubicin for patients with unresectable HCC to evaluate the overall response rate (ORR) and the toxicity. Forty patients with inoperable, systemic chemotherapy naive HCC were enrolled. Finally, 32 patients received oxaliplatin (130 mg/m(2)) and doxorubicin (60 mg/m(2)) every 3 weeks. Eighty-two treatment cycles were administered (median 2 cycles, range 1-6). There was no treatment-related mortality. The ORR was 15.6% (95% CI, 3.3-28.7) with five partial responses. The median overall survival and median overall progression free survival were 31 weeks (95% CI, 22-40 weeks) and 12 weeks (95% CI, 5-19 weeks). Nausea and peripheral neuropathy were most frequent non-hematologic toxicities (nausea, n = 15; peripheral neuropathy, n = 10). The most frequent grade 3-4 hematologic adverse event was neutropenia (14 of 82 cycles) including three cases of febrile neutropenia. The combination of oxaliplatin and doxorubicin showed modest activity and a tolerable toxicity profile in advanced HCC patients.
References
May 1, 1977·Cancer·C L VogelJ L Ziegler
May 13, 1978·Lancet·P J JohnsonI M Murray-Lyon
May 1, 1992·British Journal of Cancer·P J JohnsonR Williams
Sep 1, 1990·Journal of Hepatology·G PelletierJ P Etienne
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·J M ExtraM Marty
Dec 15, 1985·Cancer·E SciarrinoL Pagliaro
Dec 1, 1985·Liver·M ColomboM L Dioguardi
Aug 1, 1988·Cancer·C L LaiH J Lin
Feb 1, 1984·Cancer·T K ChoiJ Wong
Jan 15, 1983·Cancer·W M MeliaR Williams
Feb 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R G SimonettiL Pagliaro
Aug 8, 1998·Journal of Hepatology·G PelletierA Roche
Apr 27, 1999·Lancet·D F Schafer, M F Sorrell
Aug 11, 2000·Critical Reviews in Oncology/hematology·J L MissetE Cvitkovic
Aug 13, 2002·Journal of Korean Medical Science·Duk-Hee LeeHai-Rim Shin
Oct 3, 2003·Seminars in Oncology·James H DoroshowPercy Ivy
Jun 16, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna K NowakMichael Findlay
Jul 13, 2004·Cancer Chemotherapy and Pharmacology·Jeeyun LeeKeunchil Park
Oct 20, 2005·Journal of the National Cancer Institute·Winnie YeoPhilip J Johnson
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuKeith Stuart
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Mar 3, 2007·Cancer·Samy LouafiJulien Taïeb
Sep 19, 2007·British Journal of Cancer·V BoigeUNKNOWN Fédération Francophone de Cancérologie Digestive
Jun 19, 2012·The Oncologist·Valérie BoigeFrançoise Farace
Apr 1, 2002·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jong Myon BaeJae Gahb Park
Citations
May 27, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·F PetrelliS Barni
Oct 30, 2012·Cytotechnology·Ngoc Bich VuPhuc Van Pham
Aug 3, 2011·Investigational New Drugs·Qing ZhangZhong-Yang Shen
Jan 8, 2013·Medical Oncology·Ji-Wen Cheng, Yi Lv
May 18, 2011·Cardiovascular and Interventional Radiology·Shobu WatanabeKiyoshi Murata
Sep 29, 2009·Expert Opinion on Investigational Drugs·Zheng WangZhi Dai
Feb 18, 2016·Chinese Medical Journal·Jia-Cheng TangXiu-Jun Cai
Aug 3, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tatsuo UedaShinichiro Kumita
May 19, 2011·Asia-Pacific Journal of Clinical Oncology·Geoffrey Y KuAlex Y Chang
Jan 22, 2013·Pediatric Blood & Cancer·Leo MascarenhasRajkumar Venkatramani
Nov 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Austin DuffyTim F Greten
Apr 18, 2015·BMC Cancer·Sae Hwan LeeHeon Young Lee
Feb 11, 2015·Journal of Hepatology·Sandra M EhrlichAngelika M Vollmar
Nov 12, 2013·Journal of the Egyptian National Cancer Institute·Omar Abdel-Rahman
Oct 21, 2014·Scientific Reports·Hongming PanWeidong Han
Mar 24, 2010·Integrative Cancer Therapies·Kyung Seok KimSeong Ha Cheon
Oct 18, 2016·Medicine·Lin LiuShu-Kui Qin
Jul 13, 2019·Nanomedicine·Tengfei LiuJing Yao
Apr 26, 2014·Oncology Letters·Zhanggui WangHongming Pan
Oct 26, 2016·International Journal of Oncology·Ling GongWeibing Zhang
Oct 1, 2015·World Journal of Gastroenterology : WJG·Song GaoXu Zhu
Sep 22, 2020·Chemical Science·Junyi ChenChunju Li
Aug 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhen-Bin DingJia Fan
Jun 25, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Lorenza Rimassa, Armando Santoro